ReviewActa pharmaceutica Sinica. B2022

Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.

Steven N Austad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.